Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

HFpEF refers to when the heart is unable to pump enough blood to meet the body’s needs. Eli Lilly said the condition is ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...